DM Intelligence Ltd. Project is favored at the BIO of Philadelphia Biotechnology Exhibition
From the perspective of the development trend of the world biotechnology industry, biotechnology is at the beginning of large-scale industrialization. It is expected to enter a period of rapid development in 2020 and gradually become the leading industry of the world economy. As a strategic industry with priority development in the 21st century, the biotechnology industry is still in the initial stage of development in China.
China's biotechnology industry mainly forms three comprehensive bio-industry bases in the Yangtze River Delta, the Pearl River Delta and the Beijing-Tianjin-Hebei region, as well as the spatial layout of several specialized bio-industry bases in the Northeast and Central-Western regions. The agglomeration effect is initially apparent. The aggregation forms such as biological bases and biological parks promote the integration of biological enterprises, capital, technology, talents and other factors into advantageous areas, forming a pattern of national, local, and financial promotion of the bio-industry, thus effectively promoting the innovation of the bio-industry and accelerating technology. Industrialization process.
(Source: Prospective Industry Research Institute)
Recently, DM Intelligence Ltd. Technology team attended the 2019 International Biotechnology Exhibition (BIO) conference in Philadelphia, USA. The exhibition is sponsored by the Global Biotechnology Innovation Organization of the United States. It is the annual meeting of the American Biotechnology Innovation Organization. It is also the world's largest, most professional and most influential biotechnology event.
(exhibition site)
The exhibition provides a publicity and display platform for enterprises, science parks and research and development institutions in various countries, and provides information exchange and release, technical cooperation and transactions, and risks for exhibitors through professional forums, conferences, exchange meetings, and docking negotiations. A comprehensive platform for investment and financing. At present, the exhibition will become an important platform for China's biotechnology companies to explore the global market for products and services, seek cooperation and establish channels.
(exhibition site)
In this exhibition, DM Intelligence Ltd. team took the company's new drug research and development platform and pathological diagnosis system to attend the two major projects. Many interested people have contacted and communicated with Dr. Xie Weidong, CEO of DM Intelligence Ltd., through One-on-One.
(Dr.Xie Weidong, CEO of DM Intelligence Ltd, took the stage to speak)
As the country pays more and more attention to the biotechnology industry, we believe that the international competitiveness of China's biotechnology industry will be able to catch up with the leading forces.
